Valuation: Alcon Inc.

Market Cap 35.89B 30.79B 28.75B 26.38B 49.6B 3,431B 50.42B 339B 133B 1,721B 135B 132B 5,689B P/E 2026 *
43.8x
P/E 2027 * 27.1x
Enterprise Value 38.43B 32.96B 30.78B 28.24B 53.11B 3,673B 53.98B 363B 142B 1,842B 144B 141B 6,091B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.17x
Free-Float
97.34%
Yield 2026 *
0.5%
Yield 2027 * 0.56%
1 day-0.66%
Current month+2.22%
3 months+10.27%
1 week 57.04
Extreme 57.04
57.8
1 month 54.32
Extreme 54.32
57.8
Current year 48.16
Extreme 48.16
57.92
1 year 48.16
Extreme 48.16
57.92
3 years 48.16
Extreme 48.16
57.92
5 years 48.16
Extreme 48.16
57.92
10 years 48.16
Extreme 48.16
57.92
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%0.00% - - 35.89B
-0.27%-0.58%-39.86%-6.57% 87.21B
-1.59%+0.27%-17.94%-18.97% 35.89B
+1.35%+0.28%+3.95%-17.28% 14.78B
+1.78%+8.55% - - 11.4B
-5.46%+6.36%-8.35%+653.73% 2.51B
-2.75%-7.12%-43.06%-59.44% 1.49B
-2.53%-4.94%+56.34%-6.38% 918M
-3.07%-3.97%-40.86%-22.72% 883M
+3.87%-0.66%+18.27%+10.44% 869M
Average -0.89%-0.87%-8.94%+66.60% 17.33B
Weighted average by Cap. -0.35%-2.51%-28.47%+0.18%

Financials

2026 *2027 *
Net sales 11.09B 9.51B 8.88B 8.15B 15.32B 1,060B 15.58B 105B 41.04B 532B 41.64B 40.73B 1,758B 11.77B 10.1B 9.43B 8.65B 16.27B 1,125B 16.54B 111B 43.57B 564B 44.21B 43.25B 1,866B
Net income 776M 666M 622M 570M 1.07B 74.18B 1.09B 7.34B 2.87B 37.21B 2.91B 2.85B 123B 1.25B 1.07B 1B 919M 1.73B 120B 1.76B 11.82B 4.63B 59.97B 4.7B 4.59B 198B
Net Debt 2.54B 2.17B 2.03B 1.86B 3.5B 242B 3.56B 23.96B 9.38B 122B 9.52B 9.31B 402B 1.43B 1.23B 1.14B 1.05B 1.97B 137B 2.01B 13.5B 5.29B 68.47B 5.36B 5.25B 226B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Date Price Change Volume
18/08/26 CHF 57.12 0.00% 0
17/08/26 CHF 57.12 0.00% 0
14/08/26 CHF 57.12 0.00% 0
13/08/26 CHF 57.12 0.00% 0
12/08/26 CHF 57.12 0.00% 0
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
74.25USD
Average target price
91.40USD
Spread / Average Target
+23.10%

Quarterly revenue - Rate of surprise